tiprankstipranks
TipRanksTop Financial ExpertsInsidersAmit Munshi

Amit Munshi Insider Profile

11 Followers
Amit Munshi, Director at Inhibikase Therapeutics, holds 9.80K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 403.18K shares in Inhibikase Therapeutics (Ticker: IKT), holds 777.38K shares in Zura Bio (Ticker: ZURA).
See the Hottest Stocks Based on Insider Trading >
tipranks
Amit Munshi

Amit Munshi
Inhibikase Therapeutics (IKT)
Director

Ranked #8,991 out of 108,921 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

+43.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$6M
79.63%
16.37%
3.99%
0.00%
0.00% Others
A breakdown of Amit Munshi's holdings
See the Top Stocks by Insiders

Insider Roles

Zura Bio
(ZURA)
Director
Inhibikase Therapeutics
(IKT)
Director
Arcutis Biotherapeutics
(ARQT)
Director
Pulmatrix
(PULM)
Director
+1 other positions
Roles that Amit Munshi holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Arena Pharma
(ARNA)
Rating:Informative Buy
Date:May 15, 2017 - May 15, 2018
Return:+289.00%
The most profitable trade made by Amit Munshi
See the Latest Stocks Traded by Insiders

Amit Munshi's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IKT
Inhibikase Therapeutics
Feb 24, 2026
Director
Uninformative Sell
―
$979.72K
ARQT
Arcutis Biotherapeutics
Jun 09, 2026
Director
Uninformative Buy
―
$239.00K
ARNA
Arena Pharma
Mar 11, 2022
―
Uninformative Sell
―
$0.00
PULM
Pulmatrix
―
Director
―
―
DMRA
Damora Therapeutics
―
Director
―
―
ZURA
Zura Bio
Apr 24, 2024
Director
Informative Buy
500.00K
$4.77M
EPRSQ
Epirus Biopharma
Dec 17, 2015
―
Informative Buy
23.16K
$84.99K
List of latest transactions for each holding click on a transaction to see Amit Munshi's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Amit Munshi insider profile FAQ

What is the percentage of profitable transactions made by Amit Munshi?
The percentage of profitable transactions made by Amit Munshi is 33%.
    What is the average return per transaction made by Amit Munshi?
    The average return per transaction made by Amit Munshi is 43.30%.
      What stocks does Amit Munshi hold?
      Amit Munshi holds: IKT, ARQT, ARNA, PULM, DMRA, ZURA, EPRSQ stocks.
        What was Amit Munshi’s latest transaction?
        Amit Munshi latest transaction was an Uninformative Buy of ―.
          What was Amit Munshi's most profitable transaction?
          Amit Munshi’s most profitable transaction was an Informative Buy of ARNA stock on May 15, 2017. The return on the trade was 289.00%.
            What is Amit Munshi's role in Inhibikase Therapeutics?
            Amit Munshi's role in Inhibikase Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.